Gregory Scott Duncan, Chief Executive Officer at Virios Therapeutics, Inc. (VIRI), bought 382 shares at $6.36 ($2K) on 2021-04-06, disclosed to the SEC on 2021-04-07.
Scheduled purchase ($2k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VIRI | BUY | 2021-12-22 | $28K | — | Filing → |
| VIRI | BUY | 2021-04-06 | $193K | — | Filing → |